Zambanini Adam Dante reported option exercise involving 2,170 derivative units of TREX CO INC at $0.00 for $0 on Nov 5, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
President and CEO
President and CEO
Filed Nov 9, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
2,170Stock Appreciation Right
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 5, 2026Option exercise
Filed
Nov 9, 2026, 4:29 PM ET4-day reporting delay
Accession
0001069878-26-000085Code M · Transaction 395960
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Sell500$55.84−$27,920Trade 395959
Nov 5, 2026Option exercise1,491$56.01$83,510.91Trade 395958
3 transaction rows in this filing. Joint filers share the same rows.

TREX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TREX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −10%1w ago +1.7%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents 1,491 shares of common stock issued upon settlement of the exercise of 2,170 stock appreciation rights reported in Table II. The number of shares issued was determined based on the excess of the fair market value of the Issuer's common stock on the exercise date over the SAR grant price. F2: The shares were sold to satisfy tax obligations arising from the exercise of the stock appreciation rights reported herein. F3: The price reported represents the weighted average sale price. The shares were sold in multiple transactions at prices ranging from $55.825 to $55.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price within the range set forth herein. F4: Represents the exercise of 2,170 stock appreciation rights. Each stock appreciation right entitled the Reporting Person, upon exercise, to receive the excess of the fair market value of one share of the Issuer's common stock on the exercise date over the SAR grant price of $17.523 per share. Based on a fair market value of $56.01 per share on the exercise date, the exercise was settled through the issuance of 1,491 shares of common stock, as reported in Table I. Following the exercise, no stock appreciation rights remain outstanding under this award. F5: Following the reported exercise, no stock appreciation rights remain outstanding under this award. The Reporting Person continues to hold stock appreciation rights under other awards previously reported.